Emerging Radiotherapy Technologies for Head and Neck Squamous Cell Carcinoma: Challenges and Opportunities in the Era of Immunotherapy
2024

New Radiation Technologies for Head and Neck Cancer

publication Evidence: moderate

Author Information

Author(s): Kut Carmen, Quon Harry, Chen Xuguang Scott

Primary Institution: Johns Hopkins University; University of North Carolina

Hypothesis

Can emerging radiotherapy technologies improve treatment outcomes for head and neck squamous cell carcinoma (HNSCC) in the context of immunotherapy?

Conclusion

Recent advancements in radiotherapy technologies have the potential to enhance treatment efficacy and reduce side effects for patients with head and neck cancer.

Supporting Evidence

  • Intensity modulated radiotherapy (IMRT) has become the standard of care for most patients with locally advanced HNSCC.
  • Emerging technologies like intensity modulated proton therapy (IMPT) and stereotactic body radiotherapy (SBRT) are being increasingly utilized.
  • Combined treatment using radiation and immunotherapy may further improve patient outcomes.

Takeaway

Doctors are finding new ways to use radiation to treat head and neck cancer better, which can help patients feel better and live longer.

Methodology

This review summarizes the evolution of radiotherapy technologies for HNSCC, focusing on clinical evidence regarding tumor control and toxicities.

Limitations

The review highlights gaps in understanding the normal tissue complication probabilities and the relative biological effectiveness of newer radiotherapy modalities.

Digital Object Identifier (DOI)

10.3390/cancers16244150

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication